What changed
$ADSK — HOLD 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
🎯 FQ1 FY2027 (ends Apr) | reported May 28 | Rev $1.9B | EPS $2.35 vs $2.12 🟢 | Margin 28.0%
💡 Consensus underestimated profitability; the 10.8% EPS beat demonstrates operating leverage. However, post-beat expectations have likely reset, narrowing the gap for further surprise.
🏢 Business Quality: 8/10
📊 Valuation: fair – trailing P/E of 20.9x, FCF yield ~2.1%; compared to high-margin software peers with similar growth, the multiple is in line, offering no clear...
🔮 Catalyst: Next quarterly earnings report
⚖️ Hold – strong fundamentals but fair valuation and a bottom-decile quant score limit upside; wait for a pullback to add.